presentation
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Antengene Corporation Limited investor presentation from April 2024 outlining the company's pharmaceutical drug development efforts and clinical trial programs. The presentation covers investigational drug candidates and commercialization efforts focused on treating patients beyond borders.
investor_presentation
68 Pages
investor_presentation
44 Pages
Zions Bancorporation
Sustainable Packaging Solutions Roadshow 2023
investor_presentationinvestor_presentation
99 Pages
Becoming the first choice in sustainable packaging solutions
investor_presentation
Conn’s
